Skip to content

A randomized, placebo-controlled, double-blind, parallel-group trial of observations of subjective and objective symptoms of eye fatigue and testing for improvement with the ingestion of bilberry extract

A randomized, placebo-controlled, double-blind, parallel-group trial of observations of subjective and objective symptoms of eye fatigue and testing for improvement with the ingestion of bilberry extract - A randomized, placebo-controlled, double-blind, parallel-group trial of observations of subjective and objective symptoms of eye fatigue and testing for improvement with the ingestion of bilberry extract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035908
Enrollment
36
Registered
2019-02-18
Start date
2019-02-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

4-week intake of the containing bilberry extract food of 1 capsule a day 4-week intake of the placebo food of 1 capsule a day

Sponsors

HUMA R&D CORP
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Healthy Japanese men and women aged 25 to 40 years 2) People who feel tired of their eyes 3) Persons who routinely perform PC (PC) tasks or driving a car 4) Persons who have not undergone LASIK surgery (myopia correction surgery) 5) Subjects with uncorrected visual acuity of 0.2 or better at both eyes. 6) Persons who can be contacted by personal computers or smartphones 7) Persons with a BMI of 25 kg/m2 or less 8) People who can play games with smartphones for about 30 minutes 9) Subjects who are able to discontinue eye drops during the study period"

Exclusion criteria

Exclusion criteria: 1) Patients who are currently receiving any medications or outpatient 2) Subjects currently undergoing exercise or diet therapy under the supervision of a physician 3) Persons with a history or current disease or complication of liver disease or serious diseases of renal, endocrine, cardiovascular, gastrointestinal, pulmonary, hematological, or metabolic origin. 4) Persons who have been treated or had a history of chronic disease (arrhythmia, liver, kidney, cerebrovascular disease, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or other chronic diseases) 5) Persons who have had surgery of the digestive tract (appendicitis is allowed) 6) People who have pollinosis 7) Patients with ocular diseases other than refractive errors (hyperopia, myopia, astigmatism) 8) Persons with a history of drug allergy or food allergy 9) Those who wish to do so during pregnancy, lactation, or the study period. 10) Those who have received blood donations or vaccinations within the previous three months or who are scheduled to do so during the study period. 11) Persons who regularly consume health foods, supplements, and medicines that may affect eye function. 12) Persons who are in hospital due to mental disorders (depression etc.), sleeping disorders, etc., or who have a past medical history in the past. 13) Persons who are under treatment or have a history of alcohol dependence, drug dependence or drug abuser. 14) Person who is in shift work such as night work 15) Extremely irregular lifestyle, such as eating and sleeping 16) Current smokers 17) Subjects who have participated in other clinical trials or are currently participating in other clinical trials within the past 3 months of the date of informed consent. 18) Persons who have difficulty complying with the records of various surveys 19) Other persons for whom the principal investigator judges it inappropriate for the study. "

Design outcomes

Primary

MeasureTime frame
Visual fatigue

Countries

Japan

Contacts

Public ContactDaisuke Ochitani

HUMA R&D CORP Clinical Development Division

ochitani@huma-rd.co.jp03-3431-1260

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026